Brain Tumor Pathology
metrics 2024
Pioneering studies that shape the future of oncology.
Introduction
Brain Tumor Pathology is a pivotal peer-reviewed journal published by SPRINGER JAPAN KK, focusing on the intricate and evolving field of brain tumor research. Established in 1997, the journal serves as a crucial platform for disseminating research findings, clinical studies, and reviews that advance our understanding of brain tumors and their pathology. With a notable impact factor, it ranks in the Q2 and Q3 quartiles in multiple categories, including Cancer Research, Medicine (miscellaneous), Neurology (clinical), and Oncology, reflecting its significance in enhancing scientific discourse and clinical practice. The journal is indexed by major databases, making it accessible to a wide audience of researchers, clinicians, and students who are dedicated to unraveling the complex mechanisms of brain tumors. Although it does not currently offer open access, its comprehensive articles and studies contribute to the vital conversation on brain tumor pathologies, treatment prospects, and innovation in the field. Researchers and professionals alike will find the insights and advancements presented in Brain Tumor Pathology indispensable for guiding future studies and improving clinical outcomes.
Metrics 2024
Metrics History
Rank 2024
Scopus
IF (Web Of Science)
JCI (Web Of Science)
Quartile History
Similar Journals
Journal of Clinical and Experimental Hematopathology
Empowering Researchers with Open Access Discoveries.The Journal of Clinical and Experimental Hematopathology, published by the Japanese Society of Lymphoreticular Tissue Research, is a vital resource dedicated to advancing the field of hematopathology. With an impressive Open Access model since 2019, this journal provides researchers, clinicians, and students from around the world with unfettered access to cutting-edge research and developments in hematology and pathophysiology. Based in Japan, it has established a prominent reputation in the academic community, boasting a Q3 quartile ranking in Hematology and Q1 rankings in both Medicine (Miscellaneous) and Pathophysiology as of 2023. With its innovative contributions and high visibility, the journal not only fosters scholarly discourse but also impacts clinical practices, making it an essential publication for anyone interested in the complexities of hematologic disorders. For submissions and further inquiries, the journal is located at Nagoya University Graduate School of Medicine, Japan.
NEURO-ONCOLOGY
Exploring Innovative Treatments in Neuro-OncologyNEURO-ONCOLOGY, a leading journal published by OXFORD UNIVERSIT PRESS INC, is at the forefront of research in the intersection of neurology and oncology, with contributions spanning from 1999 to 2024. With a recognized impact reflected in its strong ranking, holding Q1 status in Cancer Research, Neurology (Clinical), and Oncology categories, NEURO-ONCOLOGY provides a vital platform for the dissemination of groundbreaking studies and advancements in brain tumor research and treatment. The journal ranks impressively within the 99th percentile in clinical neurology and 96th percentile in oncology, highlighting its significance and influence within the field. Accessible through institutional subscriptions, it serves as a valuable resource for researchers, healthcare professionals, and students seeking to stay informed of the latest developments, therapeutic strategies, and scientific discussions in neuro-oncology.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
Exploring the complexities of gynecological diseases.INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, published by Lippincott Williams & Wilkins, is a premier academic journal dedicated to the intricate field of gynecological pathology, serving a critical role in advancing the understanding of diseases related to women's reproductive health. Since its inception in 1982, this journal has established itself as a key resource for researchers, clinicians, and students, with a current impact factor that reflects its esteemed reputation; it is ranked in the Q2 category for both Obstetrics and Gynecology, as well as Pathology and Forensic Medicine, signifying its prominence in academic circles. The journal's scope encompasses a wide array of topics, including histopathological findings, diagnostic methodologies, and evolving therapeutic strategies, all pivotal to enhancing patient care. With a steadfast commitment to disseminating high-quality research until the projected year of 2024, the INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY is an essential read for those looking to stay abreast of the latest developments in this vital area of medical science.
Veterinary and Comparative Oncology
Innovating treatments, enhancing lives: the future of veterinary oncology.Veterinary and Comparative Oncology is a leading academic journal published by WILEY, providing a vital platform for the dissemination of groundbreaking research in the field of veterinary oncology. With an impressive impact factor and ranked as Q1 in the Veterinary (Miscellaneous) category for 2023, the journal is recognized for its quality and influence, placing it in the top 10% of its field. Covering a wide array of topics, from the pathogenesis of tumors in animals to innovative treatment strategies, it aims to enhance the understanding of cancer biology and therapy in veterinary medicine. The journal has an E-ISSN of 1476-5829, with its scope expanding from 2007 to 2024, reflecting an ongoing commitment to the advancement of veterinary science. Located in the United Kingdom, its global reach facilitates the exchange of knowledge among researchers, professionals, and students. For those interested in significant and impactful studies, Veterinary and Comparative Oncology remains an essential resource in the ever-evolving landscape of veterinary medicine.
CANCER SCIENCE
Exploring the forefront of cancer science and medicine.Cancer Science, an esteemed journal published by Wiley, stands at the forefront of oncology research, boasting an impressive impact factor and a classification in the Q1 category for its contributions in Cancer Research, Medicine, and Oncology as of 2023. Since its inception in 2003 and transitioning to an Open Access model in 2014, the journal has facilitated global dissemination of critical research findings, ensuring that vital information remains accessible to researchers, clinicians, and students alike. With its comprehensive scope covering cutting-edge discoveries in cancer biochemistry, genetics, and molecular biology, Cancer Science is recognized for its rigorous peer-review process and significant contributions to advancing our understanding of cancer. The journal, located at 111 River St, Hoboken, NJ, is an essential resource for anyone dedicated to improving treatment outcomes and pushing the boundaries of cancer research.
NEOPLASMA
Deepening Understanding of Neoplastic MechanismsNEOPLASMA is a prominent journal published by AEPRESS SRO, dedicated to the multifaceted field of oncology and cancer research. Since its inception in 1957, this esteemed publication has served as a vital platform for advancing the understanding of neoplastic diseases, disseminating high-quality research findings that contribute to clinical and laboratory advancements. Operating under a robust framework of peer review, NEOPLASMA holds significant credibility, as evidenced by its Q2 ranking in the Medicine (miscellaneous) category and Q3 rankings in both Cancer Research and Oncology for 2023. Furthermore, with an ISSN of 0028-2685 and E-ISSN 1338-4317, the journal fosters accessibility to valuable scientific content despite the absence of open access options. Positioned in Bratislava, Slovakia, NEOPLASMA continues to attract a global readership, making substantial contributions to the fields of biochemistry, genetics, and molecular biology as highlighted by its Scopus rankings. This journal is essential reading for researchers, professionals, and students looking to stay abreast of the latest developments in cancer research and treatment strategies.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY
Elevating Surgical Pathology Through Research ExcellenceThe American Journal of Surgical Pathology, published by Lippincott Williams & Wilkins, is a premier peer-reviewed journal serving as a vital resource for pathologists, surgeons, and researchers in the medical field. With an impressive impact factor reflective of its esteemed standing in the academic community, the journal ranks in the Q1 quartile for Anatomy, Pathology and Forensic Medicine, and Surgery as of 2023. The journal's Scopus rankings further highlight its significance, placing it within the top tiers in multiple medical disciplines. Established in 1977 and continuing through 2024, its scope encompasses groundbreaking research, critical reviews, and updates in surgical pathology, making it an essential tool for advancing the scientific community's understanding of disease mechanisms and therapeutic approaches. Researchers, clinicians, and students will find both comprehensive studies and innovative insights, ensuring they remain informed about the latest developments in surgical pathology.
ENDOCRINE PATHOLOGY
Connecting Research and Clinical Excellence in EndocrinologyENDOCRINE PATHOLOGY is a premier journal published by HUMANA PRESS INC, dedicated to advancing the understanding of endocrine disorders through innovative research and clinical practices. With an impressive impact factor and consistently ranked in the Q1 quartile across multiple categories such as Endocrinology, Diabetes and Metabolism, as well as Pathology and Forensic Medicine, this journal serves as a pivotal resource for researchers and professionals in the field. The journal covers a broad spectrum of topics related to endocrine pathology, providing insights into mechanisms, diagnostics, and therapeutics that inform both clinical and laboratory practices. Although it does not offer open access, its rigorous peer-review process ensures the dissemination of high-quality, impactful research that shapes clinical strategies and enhances patient care. With distribution spanning from its inception in 1990 to 2024, ENDOCRINE PATHOLOGY stands at the forefront of endocrine research, making it an essential read for anyone involved in the study and treatment of endocrine disorders.
PATHOLOGY INTERNATIONAL
Innovating Insights for a Healthier TomorrowPATHOLOGY INTERNATIONAL, published by WILEY, stands as a distinguished journal in the field of pathology and forensic medicine, serving as an essential resource for researchers, clinicians, and students alike. With its ISSN 1320-5463 and E-ISSN 1440-1827, PATHOLOGY INTERNATIONAL has established itself since its inception in 1951, navigating through an evolving landscape in medical science with insights and breakthroughs up to 2024. It holds a commendable Q2 ranking in both the Medicine (miscellaneous) and Pathology and Forensic Medicine categories, indicating its robust influence and quality within these fields, as evidenced by its placement in the 70th percentile of Scopus rankings. While currently not an open-access journal, it provides access options that ensure valuable research remains available to the academic community. PATHOLOGY INTERNATIONAL commits to advancing the discipline through pioneering research articles, comprehensive reviews, and expert opinions that push the boundaries of understanding in pathology, thereby supporting the enhancement of diagnostic and therapeutic practices.
Diagnostic Pathology
Elevating Diagnostics with Groundbreaking FindingsDiagnostic Pathology is a prominent open-access journal published by BMC, dedicated to advancing the field of pathology by providing a platform for high-quality research findings since its inception in 2006. Based in the United Kingdom, the journal covers a broad spectrum of topics within the realms of histology, pathology, and forensic medicine, facilitating discussions that are crucial for both clinical and laboratory settings. With an impressive impact factor that places it in the Q2 category across multiple categories including Histology and Miscellaneous Medicine, it ranks favorably in Scopus with notable positions in the 71st and 55th percentiles for Pathology and Histology respectively. As a valuable resource for researchers, professionals, and students alike, Diagnostic Pathology promotes the dissemination of cutting-edge studies and findings, thereby contributing significantly to the evolving landscape of medical science. The journal’s commitment to open access enhances its accessibility, ensuring that valuable research is freely available to a global audience.